Comprehensive Review on Current Interventions, Diagnostics, and Nanotechnology Perspectives against SARS-CoV-2

The coronavirus disease 2019 (COVID-19) has dramatically challenged the healthcare system of almost all countries. The authorities are struggling to minimize the mortality along with ameliorating the economic downturn. Unfortunately, until now, there has been no promising medicine or vaccine available. Herein, we deliver perspectives of nanotechnology for increasing the specificity and sensitivity of current interventional platforms toward the urgent need of quickly deployable solutions. This review summarizes the recent involvement of nanotechnology from the development of a biosensor to fabrication of a multifunctional nanohybrid system for respiratory and deadly viruses, along with the recent interventions and current understanding about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

[1]  I Rovira,et al.  Nitric oxide , 2021, Reactions Weekly.

[2]  S. Nelson,et al.  COVID‐19 drug repurposing: Summary statistics on current clinical trials and promising untested candidates , 2020, Transboundary and emerging diseases.

[3]  A. Tsatsakis,et al.  SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches—Insights into Chemical Structure—Biological Activity and Toxicological Screening , 2020, Journal of clinical medicine.

[4]  P. Conti,et al.  Dexamethasone for COVID-19? Not so fast. , 2020, Journal of biological regulators and homeostatic agents.

[5]  Emily G McDonald,et al.  A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 , 2020, The New England journal of medicine.

[6]  J. Peiris,et al.  Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections. , 2020, Cell reports.

[7]  J. Peiris,et al.  Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections. , 2020, Cell reports.

[8]  Amit N. Patel,et al.  RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis , 2020, The Lancet.

[9]  Fang Li,et al.  Cell entry mechanisms of SARS-CoV-2 , 2020, Proceedings of the National Academy of Sciences.

[10]  Sonu Gandhi,et al.  eCovSens-Ultrasensitive Novel In-House Built Printed Circuit Board Based Electrochemical Device for Rapid Detection of nCovid-19 antigen, a spike protein domain 1 of SARS-CoV-2 , 2020, bioRxiv.

[11]  V. Pelechano,et al.  Rapid detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform , 2020, Clinical chemistry.

[12]  Daeui Park,et al.  Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor , 2020, ACS nano.

[13]  G. Kullak-Ublick,et al.  Dual-Functional Plasmonic Photothermal Biosensors for Highly Accurate Severe Acute Respiratory Syndrome Coronavirus 2 Detection , 2020, ACS nano.

[14]  J. Lisziewicz,et al.  Precision COVID-19 Vaccine with Companion Diagnostics , 2020, Precision Nanomedicine.

[15]  Stefano Pascarella,et al.  Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy , 2020, Journal of Infection.

[16]  Zacharias E. Andreadakis,et al.  The COVID-19 vaccine development landscape , 2020, Nature Reviews Drug Discovery.

[17]  Hongming Miao,et al.  Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study , 2020, Signal Transduction and Targeted Therapy.

[18]  L. Saif VACCINES FOR COVID-19: PERSPECTIVES, PROSPECTS, AND CHALLENGES BASED ON CANDIDATE SARS, MERS, AND ANIMAL CORONAVIRUS VACCINES , 2020, European Medical Journal.

[19]  Tony Y. Hu,et al.  Insights from nanomedicine into chloroquine efficacy against COVID-19 , 2020, Nature Nanotechnology.

[20]  O. Tsang,et al.  Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study , 2020, The Lancet Infectious Diseases.

[21]  M. Cascella,et al.  Features, Evaluation and Treatment Coronavirus (COVID-19) , 2020 .

[22]  Mandeep R. Mehra,et al.  COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal , 2020, The Journal of Heart and Lung Transplantation.

[23]  Rui-guang Zhang,et al.  Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  Han-Ming Shen,et al.  Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19 , 2020, International journal of biological sciences.

[25]  Cynthia Liu,et al.  Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases , 2020, ACS central science.

[26]  A. Walls,et al.  Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.

[27]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[28]  Z. Memish,et al.  Remdesivir as a possible therapeutic option for the COVID-19 , 2020, Travel Medicine and Infectious Disease.

[29]  Jia Zhou,et al.  Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential , 2020, ACS infectious diseases.

[30]  Dyna Rochmyaningsih Indonesia finally reports two coronavirus cases. Scientists worry it has many more , 2020 .

[31]  W. Tu,et al.  Clinical features and short-term outcomes of 18 patients with corona virus disease 2019 in intensive care unit , 2020, Intensive Care Medicine.

[32]  Bin Du,et al.  Critical care crisis and some recommendations during the COVID-19 epidemic in China , 2020, Intensive Care Medicine.

[33]  Tai Hing Lam,et al.  Mass masking in the COVID-19 epidemic: people need guidance , 2020, The Lancet.

[34]  Anders Wolff,et al.  2019 Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics , 2020, Micromachines.

[35]  N. Tanner,et al.  Rapid Molecular Detection of SARS-CoV-2 (COVID-19) Virus RNA Using Colorimetric LAMP , 2020, medRxiv.

[36]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[37]  De-Min Han,et al.  Gender Differences in Patients With COVID-19: Focus on Severity and Mortality , 2020, Frontiers in Public Health.

[38]  Ping Liu,et al.  A Peptide-based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019 (COVID-19) , 2020, medRxiv.

[39]  Long Jiang Zhang,et al.  Coronavirus Disease 2019 (COVID-19): A Perspective from China , 2020, Radiology.

[40]  Young-Jun Park,et al.  Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.

[41]  Huachen Zhu,et al.  Identification of 2019-nCoV related coronaviruses in Malayan pangolins in southern China , 2020, bioRxiv.

[42]  Michael B. Chancellor,et al.  Rapid Detection of Novel Coronavirus (COVID-19) by Reverse Transcription-Loop-Mediated Isothermal Amplification , 2020, medRxiv.

[43]  DermaMed Otc Aluminum Hydroxide , 2020, Definitions.

[44]  Federico M Giorgi,et al.  Genomic variance of the 2019‐nCoV coronavirus , 2020, Journal of medical virology.

[45]  Yan Zhao,et al.  A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) , 2020, Military Medical Research.

[46]  Gengfu Xiao,et al.  Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro , 2020, Cell Research.

[47]  J. Stephenson Coronavirus Outbreak-an Evolving Global Health Emergency. , 2020, JAMA health forum.

[48]  E. Holmes,et al.  A new coronavirus associated with human respiratory disease in China , 2020, Nature.

[49]  Kai Zhao,et al.  A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.

[50]  S. Lindstrom,et al.  First Case of 2019 Novel Coronavirus in the United States , 2020, The New England journal of medicine.

[51]  Huji Xu,et al.  The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes , 2020, bioRxiv.

[52]  Christian Drosten,et al.  The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells , 2020, bioRxiv.

[53]  E. Holmes,et al.  Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding , 2020, The Lancet.

[54]  Ting Yu,et al.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.

[55]  Weier Wang,et al.  Updated understanding of the outbreak of 2019 novel coronavirus (2019‐nCoV) in Wuhan, China , 2020, Journal of medical virology.

[56]  Jing Zhao,et al.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.

[57]  W. Lipkin,et al.  From SARS-CoV to Wuhan 2019-nCoV Outbreak: Similarity of Early Epidemic and Prediction of Future Trends , 2020, bioRxiv.

[58]  G. Gao,et al.  A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.

[59]  Lisa E. Gralinski,et al.  Return of the Coronavirus: 2019-nCoV , 2020, Viruses.

[60]  S. Haam,et al.  Porous gold nanoparticles for attenuating infectivity of influenza A virus , 2020, Journal of Nanobiotechnology.

[61]  R. Baric,et al.  Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV , 2020, Nature Communications.

[62]  Wei Zhang,et al.  Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes , 2020, Emerging microbes & infections.

[63]  H. Gendelman,et al.  Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissues , 2020, Theranostics.

[64]  Naveen Vankadari,et al.  Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26 , 2020, Emerging microbes & infections.

[65]  K. To,et al.  Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan , 2020, Emerging microbes & infections.

[66]  Zhènglì Shí,et al.  Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody , 2020, bioRxiv.

[67]  F. Holsboer,et al.  SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection , 2019, Nature Communications.

[68]  M. A. Garza-Navarro,et al.  Virucidal Activity of Gold Nanoparticles Synthesized by Green Chemistry Using Garlic Extract , 2019, Viruses.

[69]  D. Shin,et al.  Inhibition of SARS-CoV 3CL protease by flavonoids , 2019, Journal of enzyme inhibition and medicinal chemistry.

[70]  Max J. Kellner,et al.  SHERLOCK: nucleic acid detection with CRISPR nucleases , 2019, Nature Protocols.

[71]  Hyojin Kim,et al.  Characteristics of flavonoids as potent MERS‐CoV 3C‐like protease inhibitors , 2019, Chemical biology & drug design.

[72]  T. Ohlmann,et al.  Selenium, Selenoproteins and Viral Infection , 2019, Nutrients.

[73]  H. Danafar,et al.  Tumor Targeted Albumin Coated Bismuth Sulfide Nanoparticles (Bi2S3) as Radiosensitizers and Carriers of Curcumin for Enhanced Chemoradiation Therapy. , 2019, ACS biomaterials science & engineering.

[74]  R. Löbenberg,et al.  Niclosamide repositioning for treating cancer: Challenges and nano-based drug delivery opportunities. , 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[75]  P. Shende,et al.  Diversity of β-cyclodextrin-based nanosponges for transformation of actives. , 2019, International journal of pharmaceutics.

[76]  Wei Zhang,et al.  Catalytic Mechanisms of Nanozymes and Their Applications in Biomedicine. , 2019, Bioconjugate chemistry.

[77]  Mauro Ferrari,et al.  Clinical Cancer Nanomedicine. , 2019, Nano today.

[78]  Jiang,et al.  Cross-Kingdom Small RNAs among Animals, Plants and Microbes , 2019, Cells.

[79]  S. Pillet,et al.  A plant-derived VLP influenza vaccine elicits a balanced immune response even in very old mice with co-morbidities , 2019, PloS one.

[80]  M. O’Connell,et al.  Molecular Mechanisms of RNA Targeting by Cas13-containing Type VI CRISPR-Cas Systems. , 2019, Journal of molecular biology.

[81]  Á. Somoza,et al.  Targeting autophagy using metallic nanoparticles: a promising strategy for cancer treatment , 2018, Cellular and Molecular Life Sciences.

[82]  S. Mostowy,et al.  Autophagy-Virus Interplay: From Cell Biology to Human Disease , 2018, Front. Cell Dev. Biol..

[83]  M. Ferrari,et al.  Chloroquine and nanoparticle drug delivery: A promising combination , 2018, Pharmacology & therapeutics.

[84]  M. Shamsipur,et al.  Recent advances in designing nanomaterial based biointerfaces for electrochemical biosensing cardiovascular biomarkers , 2018, Journal of pharmaceutical and biomedical analysis.

[85]  Leonardo Fernandes Fraceto,et al.  Nano based drug delivery systems: recent developments and future prospects , 2018, Journal of Nanobiotechnology.

[86]  Ze Chen,et al.  Comparative effectiveness of H7N9 vaccines in healthy individuals , 2018, Human vaccines & immunotherapeutics.

[87]  Hye Kyu Choi,et al.  Application of Gold Nanoparticle to Plasmonic Biosensors , 2018, International journal of molecular sciences.

[88]  M. Olesińska,et al.  Antimalarials – are they effective and safe in rheumatic diseases? , 2018, Reumatologia.

[89]  F. Trotta,et al.  Investigation of Cyclodextrin-Based Nanosponges for Solubility and Bioavailability Enhancement of Rilpivirine , 2018, AAPS PharmSciTech.

[90]  M. Shamsipur,et al.  Advances in the design of nanomaterial-based electrochemical affinity and enzymatic biosensors for metabolic biomarkers: A review , 2018, Microchimica Acta.

[91]  Xiaotao Lu,et al.  Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease , 2018, mBio.

[92]  Shi-jia Ding,et al.  Highly sensitive surface plasmon resonance biosensor for the detection of HIV-related DNA based on dynamic and structural DNA nanodevices. , 2018, Biosensors & bioelectronics.

[93]  Xiaobin Fan,et al.  Preparation of Cuprous Oxide Mesoporous Spheres with Different Pore Sizes for Non-Enzymatic Glucose Detection , 2018, Nanomaterials.

[94]  S. Baikerikar Curcumin and Natural Derivatives Inhibit Ebola Viral Proteins: An In silico Approach , 2017, Pharmacognosy research.

[95]  Jacqueline Farinha Shimizu,et al.  Flavonoids from Pterogyne nitens Inhibit Hepatitis C Virus Entry , 2017, Scientific Reports.

[96]  N. Chand,et al.  Nano cellulose dispersed chitosan film with Ag NPs/Curcumin: An in vivo study on Albino Rats for wound dressing. , 2017, International journal of biological macromolecules.

[97]  M. Chikindas,et al.  Antimicrobial efficacy of curcumin nanoparticles against Listeria monocytogenes is mediated by surface charge , 2017 .

[98]  J. Kuller,et al.  Hepatitis C in pregnancy: screening, treatment, and management. , 2017, American journal of obstetrics and gynecology.

[99]  M. Ferrari,et al.  A chloroquine-induced macrophage-preconditioning strategy for improved nanodelivery , 2017, Scientific Reports.

[100]  D. Kalman,et al.  Curcumin: A Review of Its’ Effects on Human Health , 2017, Foods.

[101]  A. Chilkoti,et al.  Niclosamide-conjugated polypeptide nanoparticles inhibit Wnt signaling and colon cancer growth. , 2017, Nanoscale.

[102]  K. Sudhakar,et al.  Green Synthesis and Characterization of Halloysite Nanoclay/Curcumin/Ag Hybrid Nano Materials for Antibacterial Applications , 2017, Journal of Inorganic and Organometallic Polymers and Materials.

[103]  M. Vignuzzi,et al.  Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding , 2017, Antiviral research.

[104]  Zhiqiang Ma,et al.  Curcumin as a potential protective compound against cardiac diseases , 2017, Pharmacological research.

[105]  J. Stoddard,et al.  Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults , 2017, Immunity & Ageing.

[106]  Aviv Regev,et al.  Nucleic acid detection with CRISPR-Cas13a/C2c2 , 2017, Science.

[107]  Jaesung Jang,et al.  Label-free Detection of Influenza Viruses using a Reduced Graphene Oxide-based Electrochemical Immunosensor Integrated with a Microfluidic Platform , 2017, Scientific Reports.

[108]  I. Wilson,et al.  Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol , 2016, Proceedings of the National Academy of Sciences.

[109]  R. Bowen,et al.  Inactivation of Middle East respiratory syndrome coronavirus (MERS‐CoV) in plasma products using a riboflavin‐based and ultraviolet light‐based photochemical treatment , 2016, Transfusion.

[110]  Hakan Inan,et al.  Advances in biosensing strategies for HIV-1 detection, diagnosis, and therapeutic monitoring. , 2016, Advanced drug delivery reviews.

[111]  James Jungho Pak,et al.  A multi-virus detectable microfluidic electrochemical immunosensor for simultaneous detection of H1N1, H5N1, and H7N9 virus using ZnO nanorods for sensitivity enhancement , 2016 .

[112]  Yànfāng Zhāng,et al.  Silver nanoparticles coated graphene electrochemical sensor for the ultrasensitive analysis of avian influenza virus H7. , 2016, Analytica chimica acta.

[113]  G. Glenn,et al.  A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age. , 2016, The Journal of infectious diseases.

[114]  K. Tanonaka,et al.  Angiotensin-converting enzyme 2. , 2016, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

[115]  C. Huang,et al.  Curcumin modified silver nanoparticles for highly efficient inhibition of respiratory syncytial virus infection. , 2016, Nanoscale.

[116]  Yang Liu,et al.  Nanozyme-strip for rapid local diagnosis of Ebola. , 2015, Biosensors & bioelectronics.

[117]  Andriy Kuzmov,et al.  Nanotechnology approaches for inhalation treatment of lung diseases. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[118]  E. Won,et al.  Combination Therapy with Lopinavir/Ritonavir, Ribavirin and Interferon-α for Middle East Respiratory Syndrome , 2015, Antiviral therapy.

[119]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[120]  Tatiana Ammosova,et al.  Inhibition of HIV-1 by curcumin A, a novel curcumin analog , 2015, Drug design, development and therapy.

[121]  Sharmistha Banerjee,et al.  The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update. , 2015, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[122]  G. Glenn,et al.  ISCOMATRIX™ adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans. , 2015, Vaccine.

[123]  Y. Chai,et al.  An amplified electrochemical immunosensor based on in situ-produced 1-naphthol as electroactive substance and graphene oxide and Pt nanoparticles functionalized CeO2 nanocomposites as signal enhancer. , 2015, Biosensors & bioelectronics.

[124]  D. Pang,et al.  Bifunctional magnetic nanobeads for sensitive detection of avian influenza A (H7N9) virus based on immunomagnetic separation and enzyme-induced metallization. , 2015, Biosensors & bioelectronics.

[125]  F. Ungaro,et al.  Toward Repositioning Niclosamide for Antivirulence Therapy of Pseudomonas aeruginosa Lung Infections: Development of Inhalable Formulations through Nanosuspension Technology. , 2015, Molecular pharmaceutics.

[126]  Xi Zheng,et al.  Curcumin, Inflammation, and Chronic Diseases: How Are They Linked? , 2015, Molecules.

[127]  A. Fatiregun,et al.  An overview of disease surveillance and notification system in Nigeria and the roles of clinicians in disease outbreak prevention and control , 2015, Nigerian medical journal : journal of the Nigeria Medical Association.

[128]  Yuming Dong,et al.  Label-free colorimetric sensor for mercury(II) and DNA on the basis of mercury(II) switched-on the oxidase-mimicking activity of silver nanoclusters. , 2015, Analytica chimica acta.

[129]  H. Ishida,et al.  Cytotoxic activities of CD8+ T cells collaborate with macrophages to protect against blood-stage murine malaria , 2015, eLife.

[130]  M. Kumari,et al.  Green synthesis and applications of Au-Ag bimetallic nanoparticles. , 2015, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[131]  Robert C. G. Martin,et al.  Gold nanorods and curcumin-loaded nanomicelles for efficient in vivo photothermal therapy of Barrett's esophagus. , 2015, Nanomedicine.

[132]  A. Mesecar,et al.  The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds , 2014, Antiviral Research.

[133]  A. Surolia,et al.  Formulation of nanotized curcumin and demonstration of its antimalarial efficacy , 2014, International journal of nanomedicine.

[134]  Q. Wei,et al.  A label-free electrochemiluminescence immunosensor based on silver nanoparticle hybridized mesoporous carbon for the detection of Aflatoxin B1 , 2014 .

[135]  A. Sirko,et al.  Plant expression systems for production of hemagglutinin as a vaccine against influenza virus. , 2014, Acta biochimica Polonica.

[136]  J. Connolly,et al.  Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers. , 2014, Vaccine.

[137]  J. Lippolis,et al.  Acute phase response elicited by experimental bovine diarrhea virus (BVDV) infection is associated with decreased vitamin D and E status of vitamin-replete preruminant calves. , 2014, Journal of dairy science.

[138]  David Heckerman,et al.  HIV Control Is Mediated in Part by CD8+ T-Cell Targeting of Specific Epitopes , 2014, Journal of Virology.

[139]  Jasmina Vidic,et al.  Electrochemical detection of the oligomerization of PB1-F2 influenza A virus protein in infected cells. , 2014, Analytical chemistry.

[140]  Piotr Orlowski,et al.  Tannic Acid Modified Silver Nanoparticles Show Antiviral Activity in Herpes Simplex Virus Type 2 Infection , 2014, PloS one.

[141]  W. Lim,et al.  The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis , 2014, The Journal of infectious diseases.

[142]  Donald J Buchsbaum,et al.  Multi-targeted therapy of cancer by niclosamide: A new application for an old drug. , 2014, Cancer letters.

[143]  R. Cavalli,et al.  The application of nanosponges to cancer drug delivery , 2014, Expert opinion on drug delivery.

[144]  K. Zandi,et al.  A Review on Antibacterial, Antiviral, and Antifungal Activity of Curcumin , 2014, BioMed research international.

[145]  S. Polyak,et al.  Arbidol as a broad-spectrum antiviral: An update , 2014, Antiviral Research.

[146]  A. Ingle,et al.  Metal nanoparticles: The protective nanoshield against virus infection , 2014, Critical reviews in microbiology.

[147]  A. Roy,et al.  Curcumin: a review , 2014 .

[148]  XinRan Li,et al.  Aluminum hydroxide nanoparticles show a stronger vaccine adjuvant activity than traditional aluminum hydroxide microparticles. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[149]  V. Vaillant,et al.  The French human Salmonella surveillance system: evaluation of timeliness of laboratory reporting and factors associated with delays, 2007 to 2011. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[150]  J. Lisziewicz,et al.  Safety, Tolerability, and Immunogenicity of Repeated Doses of DermaVir, a Candidate Therapeutic HIV Vaccine, in HIV-Infected Patients Receiving Combination Antiretroviral Therapy: Results of the ACTG 5176 Trial , 2013, Journal of acquired immune deficiency syndromes.

[151]  Byung-Chan Kim,et al.  Highly sensitive localized surface plasmon resonance immunosensor for label-free detection of HIV-1. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[152]  A. Vlasova,et al.  Effects of dietary vitamin A content on antibody responses of feedlot calves inoculated intramuscularly with an inactivated bovine coronavirus vaccine. , 2013, American journal of veterinary research.

[153]  E. Wang,et al.  Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes. , 2013, Chemical Society reviews.

[154]  Victor M Corman,et al.  Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection , 2013, The Lancet Infectious Diseases.

[155]  G. Boivin,et al.  Influenza virus resistance to neuraminidase inhibitors. , 2013, Antiviral research.

[156]  Takeshi Ono,et al.  Antiviral activity of silver nanoparticle/chitosan composites against H1N1 influenza A virus , 2013, Nanoscale Research Letters.

[157]  Cheng-Chung Chou,et al.  Nucleic Acid Sandwich Hybridization Assay with Quantum Dot-Induced Fluorescence Resonance Energy Transfer for Pathogen Detection , 2012, Sensors.

[158]  E. Riedmann Human Vaccines & Immunotherapeutics , 2012, Human Vaccines & Immunotherapeutics.

[159]  M. Zanetti,et al.  Cyclodextrin-based nanosponges as drug carriers , 2012, Beilstein journal of organic chemistry.

[160]  Heyou Han,et al.  A fast and sensitive immunoassay of avian influenza virus based on label-free quantum dot probe and lateral flow test strip. , 2012, Talanta.

[161]  S. Gorski,et al.  Targeting autophagy , 2012, Autophagy.

[162]  C. Severini,et al.  Artemisinin and artemisinin plus curcumin liposomal formulations: enhanced antimalarial efficacy against Plasmodium berghei-infected mice. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[163]  K. Imai,et al.  Inactivation of high and low pathogenic avian influenza virus H5 subtypes by copper ions incorporated in zeolite-textile materials. , 2012, Antiviral research.

[164]  Sang Yup Lee,et al.  Development of label-free optical diagnosis for sensitive detection of influenza virus with genetically engineered fusion protein. , 2012, Talanta.

[165]  S. Jo,et al.  Quantitative and sensitive detection of SARS coronavirus nucleocapsid protein using quantum dots‐conjugated RNA aptamer on chip , 2011, Journal of chemical technology and biotechnology.

[166]  T. Liang,et al.  Both innate and adaptive immunity mediate protective immunity against hepatitis C virus infection in chimpanzees , 2011, Hepatology.

[167]  G. Glenn,et al.  H5N1 Virus-Like Particle Vaccine Elicits Cross-Reactive Neutralizing Antibodies That Preferentially Bind to the Oligomeric Form of Influenza Virus Hemagglutinin in Humans , 2011, Journal of Virology.

[168]  G. Glenn,et al.  Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico , 2011, Vaccine.

[169]  Bryan C Dickinson,et al.  Chemistry and biology of reactive oxygen species in signaling or stress responses. , 2011, Nature chemical biology.

[170]  Maosheng Yao,et al.  Integrating silicon nanowire field effect transistor, microfluidics and air sampling techniques for real-time monitoring biological aerosols. , 2011, Environmental science & technology.

[171]  V. Ward,et al.  Cross‐presentation of epitopes on virus‐like particles via the MHC I receptor recycling pathway , 2011, Immunology and cell biology.

[172]  Xianggang Liu,et al.  Electrochemical detection of avian influenza virus H5N1 gene sequence using a DNA aptamer immobilized onto a hybrid nanomaterial-modified electrode , 2011 .

[173]  F. Aqil,et al.  Advanced Drug Delivery Systems of Curcumin for Cancer Chemoprevention , 2011, Cancer Prevention Research.

[174]  Kwok-Hung Chan,et al.  Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[175]  Jianrong Li,et al.  Vesicular Stomatitis Virus as a Vector To Deliver Virus-Like Particles of Human Norovirus: a New Vaccine Candidate against an Important Noncultivable Virus , 2011, Journal of Virology.

[176]  Kai Ludwig,et al.  Inhibition of influenza virus infection by multivalent sialic-acid-functionalized gold nanoparticles. , 2010, Small.

[177]  P. Giustetto,et al.  Nanosponge formulations as oxygen delivery systems. , 2010, International journal of pharmaceutics.

[178]  A. Arnold,et al.  Sex differences in renal angiotensin converting enzyme 2 (ACE2) activity are 17β-oestradiol-dependent and sex chromosome-independent , 2010, Biology of Sex Differences.

[179]  F. Plummer,et al.  Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology , 2010, mAbs.

[180]  Fang Li,et al.  Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor , 2009, Proceedings of the National Academy of Sciences.

[181]  M. Meade,et al.  Critically ill patients with 2009 influenza A(H1N1) infection in Canada. , 2009, JAMA.

[182]  Chien Chou,et al.  Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in human serum using a localized surface plasmon coupled fluorescence fiber-optic biosensor , 2009, Biosensors and Bioelectronics.

[183]  W. Barthlott,et al.  Superhydrophobic and superhydrophilic plant surfaces: an inspiration for biomimetic materials , 2009, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[184]  T. Burke,et al.  An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells. , 2009, International journal of pharmaceutics.

[185]  A. McMichael,et al.  T Cell Responses to Whole SARS Coronavirus in Humans1 , 2008, The Journal of Immunology.

[186]  Christian Melander,et al.  Inhibition of HIV fusion with multivalent gold nanoparticles. , 2008, Journal of the American Chemical Society.

[187]  S. Polyak,et al.  Arbidol: a broad-spectrum antiviral compound that blocks viral fusion. , 2008, Current medicinal chemistry.

[188]  Yung-Hyun Choi,et al.  Curcumin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-stimulated BV2 microglia , 2007, Acta Pharmacologica Sinica.

[189]  Yu Zhang,et al.  Intrinsic peroxidase-like activity of ferromagnetic nanoparticles. , 2007, Nature nanotechnology.

[190]  Po-Huang Liang,et al.  Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. , 2007, Journal of medicinal chemistry.

[191]  Y. Cheung,et al.  Induction of T-cell response by a DNA vaccine encoding a novel HLA-A*0201 severe acute respiratory syndrome coronavirus epitope , 2007, Vaccine.

[192]  Jae-We Cho,et al.  Curcumin attenuates the expression of IL-1β, IL-6, and TNF-α as well as cyclin E in TNF-α-treated HaCaT cells; NF-κB and MAPKs as potential upstream targets , 2007 .

[193]  E. Hempelmann Hemozoin Biocrystallization in Plasmodium falciparum and the antimalarial activity of crystallization inhibitors , 2007, Parasitology Research.

[194]  D. Leclerc,et al.  Proteasome-Independent Major Histocompatibility Complex Class I Cross-Presentation Mediated by Papaya Mosaic Virus-Like Particles Leads to Expansion of Specific Human T Cells , 2006, Journal of Virology.

[195]  D. Tough,et al.  Direct Stimulation of T Cells by Type I IFN Enhances the CD8+ T Cell Response during Cross-Priming1 , 2006, The Journal of Immunology.

[196]  D. Hui An overview on severe acute respiratory syndrome (SARS). , 2005, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[197]  J. Sprent,et al.  Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection , 2005, The Journal of experimental medicine.

[198]  N. Seidah,et al.  Chloroquine is a potent inhibitor of SARS coronavirus infection and spread , 2005, Virology Journal.

[199]  M. Yacamán,et al.  Interaction of silver nanoparticles with HIV-1 , 2005, Journal of nanobiotechnology.

[200]  M. Moskovits Surface‐enhanced Raman spectroscopy: a brief retrospective , 2005 .

[201]  J. Klingström,et al.  Nitric Oxide Inhibits the Replication Cycle of Severe Acute Respiratory Syndrome Coronavirus , 2005, Journal of Virology.

[202]  P. Chan,et al.  Use of convalescent plasma therapy in SARS patients in Hong Kong , 2004, European Journal of Clinical Microbiology and Infectious Diseases.

[203]  Jindrich Cinatl,et al.  Ribavirin and interferon-β synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines , 2004, Biochemical and Biophysical Research Communications.

[204]  Gengfeng Zheng,et al.  Electrical detection of single viruses. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[205]  Jie Li,et al.  Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors1 , 2004, The Journal of Immunology.

[206]  B. Murphy,et al.  An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus , 2004, Nature Medicine.

[207]  Jinfang Zhang,et al.  Piezoelectric immunosensor for SARS-associated coronavirus in sputum. , 2004, Analytical chemistry.

[208]  B. Murphy,et al.  Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[209]  J. Sung,et al.  Retrospective comparison of convalescent plasma with continuing high‐dose methylprednisolone treatment in SARS patients , 2004, Clinical Microbiology and Infection.

[210]  G. Navis,et al.  Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis , 2004, The Journal of pathology.

[211]  Jindrich Cinatl,et al.  HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus , 2004, Biochemical and Biophysical Research Communications.

[212]  W. Barclay,et al.  Changes in in vitro susceptibility of influenza A H3N2 viruses to a neuraminidase inhibitor drug during evolution in the human host. , 2004, The Journal of antimicrobial chemotherapy.

[213]  Tae Woo Kim,et al.  Generation and Characterization of DNA Vaccines Targeting the Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus , 2004, Journal of Virology.

[214]  Y. Guan,et al.  Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings , 2004, Thorax.

[215]  H. Hemilä Vitamin C and SARS coronavirus , 2003, The Journal of antimicrobial chemotherapy.

[216]  P. Borrow,et al.  Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon , 2003, Nature Immunology.

[217]  H. Powers Riboflavin (vitamin B-2) and health. , 2003, The American journal of clinical nutrition.

[218]  Michael B Edmond,et al.  Managing SARS amidst uncertainty. , 2003, The New England journal of medicine.

[219]  D. Cyranoski Critics slam treatment for SARS as ineffective and perhaps dangerous , 2003, Nature.

[220]  S. Landolfo,et al.  The interferon system: an overview. , 2002, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[221]  F. Lechner,et al.  Cross‐presentation of virus‐like particles by skin‐derived CD8– dendritic cells: a dispensable role for TAP , 2002, European journal of immunology.

[222]  Y. Mori,et al.  Detection of loop-mediated isothermal amplification reaction by turbidity derived from magnesium pyrophosphate formation. , 2001, Biochemical and biophysical research communications.

[223]  T. Notomi,et al.  Loop-mediated isothermal amplification of DNA. , 2000, Nucleic acids research.

[224]  M. Schäfer-Korting,et al.  Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[225]  L. Simonsen,et al.  The impact of influenza epidemics on hospitalizations. , 2000, The Journal of infectious diseases.

[226]  R. Semba Vitamin A and immunity to viral, bacterial and protozoan infections , 1999, Proceedings of the Nutrition Society.

[227]  A. Amerik,et al.  HIV-I protease , 1996, Applied biochemistry and biotechnology.

[228]  P. Barnes,et al.  Nitric oxide and airway disease. , 1995, Annals of medicine.

[229]  C. Bates Vitamin A , 1995, The Lancet.

[230]  P. S. Kim,et al.  A spring-loaded mechanism for the conformational change of influenza hemagglutinin , 1993, Cell.

[231]  J. Sureshkumar,et al.  Novel Coronavirus , 2020, Research Journal of Pharmacology and Pharmacodynamics.

[232]  A. Şahin 2019 Novel Coronavirus (COVID-19) Outbreak: A Review of the Current Literature , 2020 .

[233]  The race to stop COVID-19 , 2020, The Pharmaceutical Journal.

[234]  Jin-Lai Gao,et al.  Injectable pegylated niclosamide (polyethylene glycol-modified niclosamide) for cancer therapy. , 2019, Journal of biomedical materials research. Part A.

[235]  Shervanthi Homer-Vanniasinkam,et al.  Latest developments in innovative manufacturing to combine nanotechnology with healthcare. , 2018, Nanomedicine.

[236]  P. Stenvinkel,et al.  Curcumin - A promising nutritional strategy for chronic kidney disease patients , 2018 .

[237]  B. Schnierle,et al.  Curcumin and Boswellia serrata gum resin extract inhibit chikungunya and vesicular stomatitis virus infections in vitro. , 2016, Antiviral research.

[238]  A. Raza,et al.  Turmeric : A Promising Spice for Phytochemical and Antimicrobial Activities , 2015 .

[239]  M. Carafa,et al.  Liposomal chemotherapeutics. , 2013, Future oncology.

[240]  E. Patel NANOSPONGE AND MICRO SPONGES: A NOVEL DRUG DELIVERY SYSTEM , 2012 .

[241]  E. Riedmann Chinese biotech partnership brings first hepatitis E vaccine to the market. , 2012, Human vaccines & immunotherapeutics.

[242]  Murali M. Yallapu,et al.  Curcumin nanoformulations: a future nanomedicine for cancer. , 2012, Drug discovery today.

[243]  M. M. Rizvi,et al.  Oral delivery of curcumin bound to chitosan nanoparticles cured Plasmodium yoelii infected mice. , 2012, Biotechnology advances.

[244]  H. Hemilä,et al.  Vitamin C for preventing and treating pneumonia. , 2007, The Cochrane database of systematic reviews.

[245]  Jae-We Cho,et al.  Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets. , 2007, International journal of molecular medicine.

[246]  J. Atherton,et al.  The effect of ascorbic acid on infection of chick-embryo ciliated tracheal organ cultures by coronavirus , 2005, Archives of Virology.

[247]  Y. Guan,et al.  Inhibition of SARS-associated coronavirus infection and replication by RNA interference. , 2003, JAMA.

[248]  J. Siennicka,et al.  [Importance of vitamin A deficiency in pathology and immunology of viral infections]. , 2002, Roczniki Panstwowego Zakladu Higieny.

[249]  W. Fawzi,et al.  Vitamin A supplements ameliorate the adverse effect of HIV-1, malaria, and diarrheal infections on child growth. , 2002, Pediatrics.

[250]  N. Cox,et al.  Global epidemiology of influenza: past and present. , 2000, Annual review of medicine.

[251]  R. Sidwell,et al.  Influenza virus resistance to neuraminidase inhibitors. , 1998, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[252]  D. Faulds,et al.  Nelfinavir. A review of its therapeutic efficacy in HIV infection. , 1998, Drugs.

[253]  M. Neal Guentzel,et al.  Escherichia, Klebsiella, Enterobacter, Serratia, Citrobacter, and Proteus , 1996 .

[254]  J. Robotham,et al.  The acute-phase response. , 1995, New horizons.

[255]  W. Wooster,et al.  Crystal structure of , 2005 .